Hardey aims to establish vanadium resource

Published 22-AUG-2018 09:58 A.M.


3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Hardey Resources (ASX:HDY) has completed due diligence on four highly prospective vanadium projects in Queensland. These are currently owned by Vanadium Mining (VanMin), a group Hardey intends to acquire.

The delineation of recent data has increased confidence in the group’s ability to geologically model, estimate and report under the JORC (2012) Code.

Importantly, Hardey has identified further historic evidence that there are 383 Aircore drill holes targeting the Toolebuc Formation along a 150 kilometre north-south trending strike which runs through the Spike, Cera and Petrie projects and within the Sharptooth prospect as indicated below.

Double the drill holes initially reported

This was a key finding as it is nearly double the circa 170 drill holes initially reported on August 13, 2013.

Management views this development as extremely positive given that it further de-risks the prospectivity for Queensland projects.

Touching on the key takeaways, Hardey Resources executive chairman, Terence Clee said, “The geology team have done a superb job uncovering incremental data points which enhances the prospect of generating a JORC compliant resource across the four Queensland projects and de-risks them further.

“Moving forward, the Board is increasingly optimistic that Hardey Resources can develop future vanadium supply chains from Australia and Argentina judging by the encouraging results already evidenced.”

Of course anything that occurs in future is speculative at this stage and investors should seek professional financial advice if considering this stock for their portfolio.

Shallow mineralisation

Encouragingly, the average drill hole depth remains shallow at 30 metres, while elevated vanadium pentoxide (V2O5) assay results verify heightened mineral prospectivity across the projects.

Assay results included 3 metres at 0.31% V2O5 from 4 metres, including 0.5 metres at 0.39% within the Sharptooth prospect.

There was also a wider intersection of 5 metres at 0.48% V2O5 from 10 metres and 3 metres at 0.47 metres from 2 metres within the Cera prospect.

Exploration could add further value

The historic data review across the Spike, Cera and Petrie projects confirmed a typically thick mineralised zone, with an average 0.23% V2O5 content.

However, indicative pXRF values of up to 0.587% V2O5 have been reported in Cera suggesting increased mineralisation potential across the projects, subject to samples being fully assayed.

Management believes the drilling methods employed across the projects could be improved by increasing the depth and utilising larger diameter drill-cores.

Typically, the Toolebuc Formation zones within the projects were not tested below 30 metres.

Potential for economic open pit mining

As many of the historic boreholes are interpreted to terminate prematurely, not capturing the entire mineralised sequence, the full potential of the project areas is still to be realised.

Consequently, there is the potential for significant exploration upside from undertaking a more thorough drilling program.

As the elevated mineralisation typically occurs in shallow environments, the projects could be amenable to shallow, open-pit mining methods, adding to their potential economic viability.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free